Immotion Group plc (LON:IMMO), the immersive entertainment group, has announced its interim results for the six months to 30 June 2021.
CEO Martin Higginson joins DirectorsTalk Interviews to discuss interim results. Martin explains what has driven these impressive results, having recorded a solid six months of profits shares his thoughts on the rest of the year, growing sales from Let’s Explore Oceans, more on Vodiac, how the Uvisan product has developed, cash generation and how it will be utilised and can Immotion really continue to grow at this pace.
· H1 2021 revenue £2.8m
· Near breakeven result in H1 – EBITDA loss £31k
· Outstanding performance in Q3 – revenue circa £3m, estimated EBITDA circa £0.6m, adjusted PBT breakeven
· Six consecutive months of underlying EBITDA profit (April-September)
· Record Group results for June, July and August
· H2 expected to be strongly cash generative. Cash on hand £0.9m (30 June 2021: £0.6m)
· Location Based Entertainment (“LBE”) division – almost all sites now open and trading
· H2 seeing growing revenue and contributions from Home Based Entertainment (“HBE”) and Uvisan
· New LBE zoo offering in production for spring 2022 launch
· New HBE product – “Vodiac” – to be beta launched in Q4 2021
· Uvisan received first significant NHS order for 64 cabinets
Robin Miller, Chairman of Immotion Group said:
“Our H1 result is very encouraging, particularly as conditions in the early part of the period remained challenging to say the least. April saw us reach underlying EBITDA profit for the first time, and we have maintained this performance every month since. Our core Location Based Entertainment (“LBE”) business has recovered strongly and enjoyed a buoyant summer period.
Following this, we have seen a very strong start to H2 and, accordingly, we expect Q3 to deliver overall Group revenue of circa £3m and EBITDA of £0.6m. Momentum is growing in our HBE and Uvisan businesses and this augurs well for Q4 when we believe, based on current performance, they will in aggregate deliver significant revenue, margin and net cash inflow.
Our LBE business will continue to focus on larger installations while creating new content to launch into the global zoo market – which we believe to be considerably larger than the aquarium market – in the early part of next year.
HBE, while continuing to build momentum with the “Let’s Explore Oceans” range of content, will also be launching an exciting new product, “Vodiac”, offering a much broader and deeper choice of channels.
Securing our first significant order for the NHS was a major milestone for Uvisan, our UV-C disinfection business. This, plus the ongoing pandemic and resultant heightened profile of workplace safety and hygiene, gives us confidence that demand for these products is going to be with us for the foreseeable future and provides a positive backdrop for growth.
The creation of the HBE and Uvisan divisions has provided us with two further significant growth opportunities and the early signs are very promising. This is a real testament to the team, its entrepreneurial spirit and determination not just to survive but to prosper.
In conclusion, we have confidence that there are plentiful growth opportunities ahead.”
We are delighted with the performance of our Group in H1. Despite a very challenging start to the year, the Group produced its best ever result with a small overall EBITDA loss for the first half of £31k on revenue of £2.8m.
This was an excellent outcome given that trading conditions in the first three months of the period were very challenging as COVID-19 restrictions persisted and many sites remained closed or severely impacted. In fact, the Group recorded an EBITDA loss of £0.2m in the first quarter.
We were delighted to see the Group finally reach underlying monthly EBITDA profit in each of the three months of the second quarter – this is a real landmark for the Group, emerging from the long periods of lockdowns to clearly demonstrate its potential.
Cost control remained a key focus and we implemented a small number of redundancies and have taken steps to reduce our occupancy costs. Administrative expenses (excluding depreciation, amortisation, impairment, share-based payments, profit/loss on asset disposals, restructuring costs and other exceptional items) fell to £1.4m (H1 2020: £1.5m), being an average of £235k per month. We expect administrative expenses to remain around this level but there may be, as would be expected, some degree of variable cost fluctuation as activity levels increase across the three businesses (e.g. travel and trade shows).
The difference between EBITDA and operating cash flow was almost entirely a result of total net working capital outflows of £0.8m in the period. This related in the main to an increase in trade and other receivables of £0.6m in the period that occurred naturally as the LBE business activity increased dramatically in Q2. Additionally, there was an overall reduction of trade and other payables of £0.2m as we caught up on liabilities that had built up during the lockdown period last year, including paying off all remaining overdue amounts to HMRC.
Inventories at period end were £163k (31 December 2020: £152k), primarily comprised of HBE stock held. In addition, the H1 closing balance sheet includes net HBE stock prepayments of £227k (comprised of stock in production/transit, less corresponding payments yet to be made). Having planned ahead, we should now be very well placed to capitalise on the key Q4 period.
Post period-end trading
The second half has begun very strongly with record results in July and August. September will be another strong month and, with the contribution of HBE and Uvisan now growing strongly, we expect overall Group revenue for Q3 to be circa £3.0m and underlying EBITDA to be circa £0.6m.
Despite the LBE division moving into its quieter period, we are confident of a profitable fourth quarter for the Group. The HBE division has seen a strong surge in revenue and margin in September and it will have plenty of stock at its disposal to deliver significant revenue, margin and cash inflow in Q4 if this trend continues. Uvisan has seen a growing order book from its reseller and distributor network and this is translating into growing revenue and contribution.
We expect H2 to be strongly cash generative, providing us with the flexibility to bring forward any stock or equipment orders to address international shipping concerns.
The Group currently has cash of £0.9m, up from £0.6m as at 30 June 2021, which reflects the extremely strong trading of the LBE business during the summer months.
We present below our review of the period and prospects for each division and the Group.
Location Based Entertainment (“LBE”)
The Group outcome in H1 was driven in the main by the recovery of the LBE Business. We saw monthly revenue in this division grow almost six-fold from January to June as sites reopened and trading conditions improved.
Total revenue in this division in the period was £2.3m and gross profit was £1.0m (being total revenue less partner share and other direct costs of sales, including rent and payroll in our ImmotionVR sites).
We believe the result is a strong endorsement of the partner model and the substantial investment made pre-pandemic to establish and grow it.
Our current portfolio is presented in the table below. I am pleased to report that almost all of our locations have now re-opened and are trading, though we expect our Australian installations in Sydney (two sites) and Melbourne (one site) to remain closed for some time to come as lockdown continues in the states of New South Wales and Victoria.
|At 1 January 2021||48||345||24||163||14||121||10||61|
|Installed in 2021||7||70||4||52||2||14||1||4|
|Uninstalled in 2021||(4)||(27)||(1)||(2)||(2)||(21)||(1)||(4)|
|At 27 September 2021||51||388||27||213||14||114||10||61|
In the period we opened seven new locations (64 headsets) including the 22-headset installation at Clearwater Marine Aquarium, Florida which opened in March 2021 and has traded very well throughout the summer. We were pleased that the agreement in relation to Clearwater has now been extended through to March 2023.
The current operational status of our installed base is as follows:
|Total Sites||Total Headsets||USA Sites||USA|
|UK Sites||UK Headsets||ROW Sites||ROW|
|At 27 September 2021||51||388||27||213||14||114||10||61|
|Site open but installation not operating||4||16||3||10||–||–||1||6|
Throughout the period we suffered reduced capacity at Shark Reef Aquarium at Mandalay Bay, our flagship Las Vegas installation, due to local restrictions but these were finally removed from 1 July 2021 and this has had a significant positive impact on subsequent trading.
Since the period end, we have seen very strong trading in our LBE business in July and August with revenue in excess of £900k in both months, though we will see the significant seasonal slow-down kick in from September as school holidays have now ended in the USA and UK.
As can be seen from the summer period, our LBE business has now reached a tipping point where its contribution can generate significant overall monthly profit for the Group in the summer months. Even in the quieter months, we believe it should at its current scale, cover most if not all of the Group’s fixed costs of operation. This combined with the busier period for HBE, as well as growing sales in Uvisan gives us a well-balanced portfolio of businesses.
The costs of operation in the LBE division should remain relatively stable with almost all gross profit from new sites now dropping straight to the EBITDA line. Even with our conservative depreciation policies on plant and equipment (we believe lifetimes of motion platforms are considerably longer than three years), new sites should add strongly to the PBT line.
We were, as previously advised, deliberately cautious this year in terms of new site openings. However, we are seeing healthy levels of enquiries from the aquarium sector, where we now enjoy a strong reputation.
We intend to launch in the zoo market in spring 2022. We have been filming new immersive, 360-degree, live action endangered species content in Africa, which we expect to unveil in Q4, when we also hope to announce initial partner zoos. We would expect installations to begin in time for spring 2022.
We believe the zoo market to be both global and several times the size of the aquarium sector, sharing the features that attracted us to the aquarium market: large numbers of high traffic, high quality potential partners, on a global basis.
For both aquariums and zoos, our focus will be where possible to open larger formats based on the know-how we have developed at Mandalay Bay, Clearwater Marine Aquarium and Sea Life Orlando. Where size allows these new installations will take the form of mini-theatres complete with pre-show areas. We want these to be exciting new core attractions for the partner sites, as well as delivering significant revenue for both parties.
In short, we believe there are plentiful growth opportunities for our LBE business which we are well placed to capitalise upon.
Home Based Entertainment (“HBE”)
We launched our HBE division with sales of Let’s Explore Oceans (“LEO”) commencing in mid-October 2020, selling only in the UK market. In Q4 2020, we sold circa 11,000 LEO packs and recorded revenue of circa £0.7m.
We always expected the LEO product to be highly seasonal, so H1 2021 was, as expected, a quieter period. For a gift type product at its price point the LEO pack was always likely to see a drop in consumer intent to purchase post-Christmas.
Accordingly, in H1 we have sought to expand the global marketing and sales of the product, delivering to a number of key countries, including USA, Canada, Australia, as well as the UK, recording revenue of £0.3m (3,000 packs).
Though it resulted in a loss after product, marketing and fulfilment costs of circa £0.1m, this period has given us an enormous amount of learning ahead of the key Q4 period for this year and enabled us to identify the most lucrative potential global markets for Q4 2021 as well as continue development of additional experiences.
Our focus for the remainder of this year will be USA, Canada, UK and Australia. With stock on hand, and stock already purchased for delivery in coming weeks, we have the potential in Q4 to sell circa 28,000 units. Having planned forward we have secured stock at substantially lower unit cost than 2020, so that even allowing for increased shipping costs in the current shipping crisis, we are well placed.
To ensure we can supply our target markets as effectively as possible, we have established third party logistics and fulfilment relationships in the UK, USA and China and we also began trading on Amazon in both the USA and UK and we are seeing growing volumes through these channels.
Customer acquisition remains our most material cost of sale and we expect this to fall in the Q4 period when demand is strongest and customer intent high. Our key marketing channels are social media sites, which allows us to access a huge addressable market very rapidly. Amazon is obviously a key channel in its own right which complements our social media activity.
We have seen a substantial uptick in the HBE business post period end, with aggregate revenue for July and August of £253k and improving, positive margins (after product cost, customer acquisition and fulfilment). September to date has been very strong with revenue on target to end the month at circa £300k, again with strong margins.
This augurs well for the balance of the year. As noted above, between stock on hand and orders placed we have circa 28,000 pieces of LEO stock, with substantial deposits having already been paid on un-delivered stock. If the metrics seen in the last few weeks continue – with average order values of in excess of £80 and strong margins per unit being achieved – we should see very substantial revenue, margin and net cash inflow in Q4 from this division.
As far as 2022 is concerned, we will be continuing to finesse the LEO product, whilst also launching a lower price point product, “Vodiac”. The new offering will boast a number of VR channels allowing us to offer a range of VR video content, both on a free and rental basis. The broadening of content, verticals and lower price point should allow us to expand significantly the potential audience. The new content, which will include our “Dinosaur Safari”, will also be made available to all existing LEO users and in good time for new users opening their parcels, which will likely be concentrated around the Christmas and festive holiday season.
This is Uvisan’s first full year of trading and H1 saw it make good progress, delivering a small but profitable contribution.
The versatility of our UV-C cabinet meant we supplied a number of sectors including education (with particular success with universities), leisure, media and healthcare, with some high-profile counterparties, including our first supplies into the NHS.
It is pleasing to note that our UV-C disinfection cabinet meets the cleaning criteria of both Microsoft (HoloLens) and Hewlett Packard for their range of VR headsets (we are specifically recommended by HP as one of only two recommended UV-C disinfection products for their headsets).
The emphasis in the period for Uvisan was very much on growing the reseller and distributor base and we are pleased to now have a network of 10 active resellers which, we believe, will benefit us in terms of volume moving forwards. We signed an exclusive distribution agreement for Australia and New Zealand and are pleased to report that the first container of product will be arriving there imminently. We continue to sign new agreements (including our first agreements for the USA) with partners who we believe have deep knowledge of, and customer relationships in, their vertical channels.
The global installed base of headsets is forecast to grow massively, particularly in training and education settings, and we intend to be a product of choice for businesses and organisations wanting hassle free and safe disinfection of their valuable headset fleets.
The second half will see a substantial increase in revenue as cabinet orders on hand from the reseller network begin to be fulfilled.
We chose to delay the launch of “Cleanroom by Uvisan” pending an official launch at a number of major healthcare related conferences which we are attending in the coming months.
Additionally, we are complementing the product range so that we can cater to a wider range of needs and budgets. We are looking to include UV-C air filtering equipment and static light arrays in our range, which we believe will give us a wider addressable audience and better equip us to compete for large healthcare and other public sector opportunities.
The objective in the coming 18 months is to grow Uvisan into a specialist in UV-C based disinfection rather than an opportunistic reseller of the cabinets. We believe that the heightened focus on disinfection as a result of the continuing COVID-19 pandemic and the growth of VR and AR headset use provide a very supportive backdrop.
Whilst not beyond doubt, it does now appear that the likelihood of protracted lockdowns because of the COVID-19 pandemic has diminished. The period since March 2021 has demonstrated the true potential of our LBE business and we will look to grow this significantly in 2022 as we launch our new zoo product and increasingly seek to focus on larger ‘dial-moving’ sites.
We believe there are huge growth opportunities in front of us in both the aquarium and zoo sectors and with a more stable environment we will look to accelerate growth as we move into 2022.
In our HBE and Uvisan businesses we have the potential for two further high growth businesses which we believe can contribute significantly to the Group and complement our LBE division.
Against this backdrop we currently feel very optimistic about our prospects for the remainder of 2021 and beyond.